Lymphatic regeneration: new insights from VEGFR-3 blockade

J Natl Cancer Inst. 2005 Jan 5;97(1):2-3. doi: 10.1093/jnci/dji015.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Humans
  • Lymphangiogenesis / drug effects*
  • Vascular Endothelial Growth Factor C / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor C / metabolism
  • Vascular Endothelial Growth Factor D / antagonists & inhibitors
  • Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors
  • Vascular Endothelial Growth Factor Receptor-3 / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor Receptor-3 / metabolism

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Vascular Endothelial Growth Factor C
  • Vascular Endothelial Growth Factor D
  • Vascular Endothelial Growth Factor Receptor-2
  • Vascular Endothelial Growth Factor Receptor-3